A circular issued on ‘good manufacturing practices’ in August describes the recall procedure as well as the law in this respect, but it is doubtful whether these provisions are implemented. The CDSCO list (and that of States) should provide details on sample size as well as the time and place of collection. Collecting samples from distributors’, chain suppliers, as today most of the drugs r purchased from such chains for additional discounts and schemes supplied to distributors and retailers from outside States, such unethical practices must be monitored
Finally, medicines are life and death matter. The industry needs the right dose of regulation and freedom
it is high time that both industry and government come together to deal with this menace
https://chat.whatsapp.com/Iili8jkCHeYJYi3x89OPuF
POV Admin Pharma Forum : Kamlesh Doshi
